mmmm....R/S???
REPORT ON STATUS OF FILING
Vancouver, Canada--(BUSINESS WIRE)-10 October 2000-The Board of Directors of Rocky
Mountain Ginseng, Inc. (Pink Sheets: RMGG) wish to report that the filing of the Form 10-SB
with the Securities and Exchange Commission is being held pending possible
reorganization of the share structure. The purpose of the restructuring would be to
allow the raising of capital for the China operations, Rocky Mountain (Fuzhou) Drug Co., Ltd.
The Company is currently in the process of discussing possible avenues of financing with
several parties.
ABOUT ROCKY MOUNTAIN GINSENG, INC.
Rocky Mountain Ginseng, Inc.?s head office is located in British Columbia, Canada. The
Company exports American ginseng to China as well as manufactures and processes
America ginseng products in China. Rocky Mountain Ginseng, Inc. holds exclusive world
processing and distribution rights to several innovative value added ginseng products
developed in North America.
Rocky Mountain Ginseng, Inc. purchased Fuzhou Fujian Drug Company located in China in
February 1999. This acquisition included all necessary drug and hygiene licenses allowing
the Company to import, export, manufacture and distribute ginseng products in all
provinces of China. The Company has completed the construction of its new office and
manufacturing facility in the city of Fuzhou and is currently producing traditional ginseng
products for the Chinese Market. The Chinese factory employs 42 people in
processing, sales, accounting and management. Rocky Mountain (Fuzhou) Drug Co. Ltd. is
the first wholly owned Canadian Company in the Fujian province.
This press release contains forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Act of 1995. Expression of future goals and
similar expressions reflecting something other than historical fact involve risks and
uncertainties. The actual results the company achieves may differ materially from any
forward-looking statements due to such risks and uncertainties.
CONTACT INFORMATION
Rocky Mountain (Fuzhou) Drug Co. Ltd.
Brian A. Hodge, President
(86) 591-379-7969 (phone)
e-mail: rockymt@public.fz.fj.cn
Website: www.RMGGInvestor.com |
